Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
NCT07768124Recruiting
- Sponsor
- Xiu Huang
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised trial in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Xiu Huang. Primary endpoint: Complete response rate of delayed-phase CINV. Started Jul 2026; status: recruiting.
02
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07768124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07768124.